Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

CRME

Ls 2x Salesforc (CRME)

Ls 2x Salesforc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
24/04/2023	16h47	UK Regulatory	Leverage Shares PLC Issuer Call Redemption Confirmation	LSE:CRME	Ls 2x Salesforc
21/12/2009	23h05	PR Newswire (US)	Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase Plans	LSE:CRME
18/12/2009	00h00	PR Newswire (US)	Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study	LSE:CRME
09/11/2009	14h40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
07/11/2009	00h00	PR Newswire (US)	Cardiome to Release Third Quarter Results	LSE:CRME
02/11/2009	20h35	PR Newswire (US)	Cardiome To Present At Oppenheimer Healthcare Conference	LSE:CRME
28/10/2009	21h58	PR Newswire (US)	Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial	LSE:CRME
17/10/2009	02h54	PR Newswire (US)	Cardiome Pharma Corp. Announces Final Results of Tender Offer	LSE:CRME
14/10/2009	12h00	PR Newswire (US)	Cardiome Pharma Corp. Announces Preliminary Results of Tender Offer	LSE:CRME
01/09/2009	20h57	PR Newswire (US)	Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender Offer	LSE:CRME
28/08/2009	19h30	PR Newswire (US)	Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of	LSE:CRME
25/08/2009	23h11	PR Newswire (US)	Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares	LSE:CRME
11/08/2009	13h45	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
11/08/2009	01h45	PR Newswire (US)	Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement	LSE:CRME
10/08/2009	22h35	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
03/08/2009	23h16	PR Newswire (US)	Cardiome Announces Management Transition	LSE:CRME
28/07/2009	17h45	PR Newswire (US)	Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.	LSE:CRME
19/05/2009	14h30	PR Newswire (US)	Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now Effective	LSE:CRME
15/05/2009	22h05	PR Newswire (US)	Cardiome Reports First Quarter Results	LSE:CRME
09/04/2009	00h13	PR Newswire (US)	Cardiome to Hold Conference Call	LSE:CRME
28/11/2008	23h31	PR Newswire (US)	Cardiome Discloses Chairman And CEO's Involuntary Share Sale	LSE:CRME
15/11/2008	00h40	PR Newswire (US)	Cardiome Reports Third Quarter Results	LSE:CRME
24/10/2008	04h40	PR Newswire (US)	Cardiome Announces Filing Of Shelf Registration Statement	LSE:CRME
09/10/2008	18h20	PR Newswire (US)	Cardiome Provides Regulatory Update	LSE:CRME
12/08/2008	22h05	PR Newswire (US)	Cardiome Reports Second Quarter Results	LSE:CRME
11/08/2008	22h30	PR Newswire (US)	Cardiome to Release Second Quarter Results and Hold Conference Call	LSE:CRME
11/08/2008	15h18	PR Newswire (US)	Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)	LSE:CRME
23/07/2008	20h10	PR Newswire (US)	Cardiome Announces Preferred Share Financing	LSE:CRME
14/07/2008	14h25	PR Newswire (US)	Cardiome Announces Positive Phase 2b Results For Oral Vernakalant	LSE:CRME
13/07/2008	18h00	PR Newswire (US)	Cardiome To Hold Conference Call	LSE:CRME

Showing the most relevant articles for your search:LSE:CRME

1 2 3 4 Next >>

Huntington Bancshares

Blancco Technology

West Japan Railway (PK)

Global X Msci Greece Etf

World Bank Sustainable T...

Leisure & Entertainment ...

MMB SCF SACA Mmb Scf 19/...

IT0005575425 20240603 120

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen